Bernice Welles

Bernice Welles

Directeur/Membre du Conseil chez
American Life Science Pharmaceutical, Inc.
73 ans
Health Technology
Consumer Services
Finance

Profil

Bernice R.
Welles
is currently a Director at American Life Science Pharmaceutical, Inc., a Member at The Endocrine Society, and a Partner at IPF Management I SARL. Previously, she worked as the Chief Executive Officer at Alquest Therapeutics, Inc. from 2010 to 2013, Vice President-Product Development at Genentech, Inc. from 1995 to 2003, Vice President-Development at DiObex, Inc. from 2005 to 2008, Chief Medical Officer at Enject, Inc. from 2009 to 2013, and as a Venture Partner at MPM BioImpact, Inc. from 2003 to 2005.
She also served as an Independent Director at Spectrum Pharmaceuticals, Inc. and as Treasurer & Director at The San Francisco Food Bank.
Dr. Welles is a graduate of Brandeis University, Tufts University, Albany Medical College, and The Wharton School of the University of Pennsylvania.

Postes actifs de Bernice Welles

SociétésPosteDébut
Corporate Officer/Principal 01/12/2010
Directeur/Membre du Conseil -
Private Equity Investor -

Anciens postes connus de Bernice Welles

SociétésPosteFin
Alquest Therapeutics, Inc.
Directeur Général 01/01/2013
Directeur Technique/Scientifique/R&D 01/12/2010
Corporate Officer/Principal 01/01/2008
Private Equity Investor 01/04/2005
Corporate Officer/Principal 31/07/2003
Voir l'expérience en détail de Bernice Welles

Formation de Bernice Welles

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

85

Relations au 1er degré

16

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées16

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Services

Commercial Services

Consumer Services

Health Technology

Consumer Services

Finance

Alquest Therapeutics, Inc.

  1. Bourse
  2. Insiders
  3. Bernice Welles
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT